Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bayer

Bayer
1863 FOUNDED
PUBLIC STATUS
>100K EMPLOYEES
BAYN STOCK SYMBOL
38 INVESTMENTS
$62.30 SHARE PRICE (As of Monday Closing)
Description

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides over half of the company's sales and includes pharmaceutical drugs as well as vitamins and animal health products. The company has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Website
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Agricultural Chemicals
Drug Discovery
Stock Exchange
ETR
Primary Office
  • Kaiser-Wilhelm-Allee 1
  • 51373 Leverkusen
  • Germany

+49 0214 000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bayer’s full profile, request a free trial.

Bayer Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$60.26 - $122.31 $58.1B $63.63 $0.93 3.84M 933M

Bayer Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 102,694,285 70,768,789 118,586,476 106,578,886
Revenue 50,315,463 46,714,105 39,488,672 38,652,051
EBITDA 4,209,259 11,758,181 7,849,240 9,501,792
Net Income 1,136,824 2,000,212 8,273,280 5,011,946
Total Assets 146,126,393 144,457,790 90,082,060 86,489,841
Total Debt 47,290,215 47,153,969 17,032,176 19,976,021
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bayer Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bayer‘s full profile, request access.

Request full access to PitchBook

Bayer Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merck Corporation Darmstadt, Germany 00000 00000000
00000000000 000000 Private Equity-Backed Mexico City, Mexico 000.00 0000000000 000.00
00000 Corporate Backed or Acquired Mumbai, India 00000 00000000
000000000000000 Corporation Brentford, United Kingdom 000000 00000000000
000000 Formerly PE-Backed Bangalore, India 00000 000.00 00000000 000.00
To view this company’s complete list of competitors, request access »

Bayer Investments & Acquisitions (38)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 02-Apr-2019 00000 00000 00 0000 Other Pharmaceuticals and Biotechnology 0000 0000000 00
00000000 07-Jun-2018 000000000000000000 0000 Agricultural Chemicals 000000 0000000
0000 00000000 (000 14-Nov-2017 000000000 00000 00 00.000 Other Commercial Services
0000 000 14-Sep-2017 00000 0000000 00000 Biotechnology
Boragen 22-Mar-2017 Early Stage VC 000.00 Other Commercial Products
To view this company’s complete investment and acquisition history, request access »

Bayer Exits (13)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 01-Jan-2008 00000 00000 00 0000 Completed
  • 4 buyers
0000 00000000 11-Jan-2006 000000000000000000 Completed
  • 00000
0000000 0000000000 25-May-2005 00000 00000 00 0000 Completed
  • 8 buyers
0000000 0000000000 29-Sep-2004 000000000000000000 Completed
  • 00000
SuNyx 08-Sep-2004 PE Growth/Expansion 00.00 Completed
  • 3 buyers
To view this company’s complete exits history, request access »

Bayer Subsidiaries (11)

Company Name Industry Location Founded
Grants4Apps Accelerator/Incubator Berlin, Germany 2014
00000 000000 Other Agriculture Berlin, Germany 0000
0000000000 0000000 Corporate Pension Leverkusen, Netherlands 0000
00000 00000000000 Corporate Pension Pittsburgh, PA 0000
00000 00000000000 Horticulture Mumbai, India 0000
To view this company’s complete subsidiary history, request access »

Bayer Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Bayer‘s full profile, request access.

Request full access to PitchBook

Bayer Executive Team (22)

Name Title Board
Seat
Contact
Info
Werner Baumann Chairman of the Board of Management & Chief Executive Officer
Philip Blake President, U.S. & Senior Bayer Representative of U.S.
Andrew Marriott Senior Legal Counsel, Country Platform / Consumer Health Business Partner
Kyra Pauly Director Corporate Strategy
Hugo Pereira Director, Corporate Strategy

8 Former Executives

You’re viewing 5 of 22 executives. Get the full list »

Bayer Board Members (24)

Name Representing Role Since Contact
Info
0000é 000 000000 Bayer Board Member 000 0000
0000000 0000000 Self Board Member 000 0000
000000 00000000 Bayer Board Member 000 0000
00000 0ö00000 Self Board Member 000 0000
00000 00000000 Bayer Board Member 000 0000

6 Former Board Members

You’re viewing 5 of 24 board members. Get the full list »